Global Female Contraceptive Market 2016-2020

  • ID: 3946594
  • Report
  • Region: Global
  • 78 pages
  • TechNavio
1 of 5

FEATURED COMPANIES

  • Afaxys
  • Ansell
  • Female Health
  • HLL Lifecare
  • Lupin Pharmaceuticals
  • Okamoto Industries
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

About Female Contraceptives

Adolescent fertility regulation and pregnancy prevention are important healthcare issues today. Although it is difficult to gauge the full extent of the unmet need for contraception, there is a great need for reproductive and sexual health education owing to the rise in STDs. Research suggests that behavior in adolescence results in a pattern for the rest of an individual’s life. The absence of sexual and reproductive healthcare programs for adolescents can result in unwanted pregnancies and unsafe abortions.

The analysts forecast the global female contraceptive market to grow at a CAGR of 3.48% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global female contraceptives market for 2016-2020. To calculate the market size, the report considers the revenue generated from the overall retail sales of female contraceptive products globally.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Female Contraceptives 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Allergan
- Merck Millipore
- Pfizer
- Teva Pharmaceuticals

Other prominent vendors
- Afaxys
- Agile Therapeutics
- Ansell
- Bayer Pharma
- Caya
- Ferring Pharmaceuticals
- Female Health
- Fuji Latex
- HLL Lifecare
- Janssen Pharmaceuticals
- Lipocine
- Lupin Pharmaceuticals
- Mayer Laboratories
- Okamoto Industries
- Reckitt Benckiser
- Syzygy Healthcare
- V-Care Pharma

Market drivers
- Growing importance of family planning
- For a full, detailed list, view the full report

Market challenges
- High cost and inaccessibility of health services
- For a full, detailed list, view the full report

Market trends
- Growing cases of sexually transmitted diseases (STDs)
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Afaxys
  • Ansell
  • Female Health
  • HLL Lifecare
  • Lupin Pharmaceuticals
  • Okamoto Industries
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

PART 01: Executive summary
  • Highlights
PART 02: Scope of the report
  • Market overview
  • Top-vendor offerings
PART 03: Market research methodology
  • Research methodology
  • Economic indicators
PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Five forces analysis
PART 06: Geographical segmentation
  • Global female contraceptive market by geography
  • Female contraceptive market in Americas
  • Female contraceptive market in EMEA
  • Female contraceptive market in APAC
PART 07: Product segmentation
  • Global female contraceptive market by product segmentation
  • Global female contraceptive market by devices
  • Global IUD market
  • Global sterilization market
  • Global subdermal contraceptive implant market
  • Global vaginal ring market
  • Global female condom market
  • Global non-surgical permanent contraception market
  • Global contraceptive diaphragm market
  • Global contraceptive sponge market
  • Global female contraceptive drug market
  • Global birth control pill market
  • Global emergency pill market
PART 08: Market drivers

PART 09: Impact of drivers

PART 10: Market challenges

PART 11: Impact of drivers and challenges

PART 12: Market trends

PART 13: Vendor landscape
  • Competitive scenario
PART 14: Key vendor analysis
  • Allergan
  • Merck Millipore
  • Pfizer
  • Teva Pharmaceuticals
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
PART 16: About the Author

List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global female contraceptive market: An overview
Exhibit 03: Advantages and disadvantages of different types of contraceptives
Exhibit 04: Effectiveness of female contraceptives
Exhibit 05: Global female contraceptive market ($ billions)
Exhibit 06: Impact factors of the global female contraceptive market
Exhibit 07: Investment opportunity in global female contraceptive market
Exhibit 08: Effectiveness of family planning methods
Exhibit 09: Top-ranked women health issues 2015
Exhibit 10: Five forces analysis
Exhibit 11: Global female contraceptive market by geography 2015-2020 (% share)
Exhibit 12: Global female contraceptive market by geography 2015-2020
Exhibit 13: Female contraceptive market in the Americas 2015-2020 ($ billions)
Exhibit 14: Percentage of women aged 15-44 using modern contraceptives in US 2015
Exhibit 15: Key leading countries
Exhibit 16: Female contraceptive market in EMEA 2015-2020 ($ billions)
Exhibit 17: Key leading countries
Exhibit 18: Female contraceptive market in APAC 2015-2020 ($ billions)
Exhibit 19: Key leading countries
Exhibit 20: Global female contraceptive market by product segmentation 2015 (% share)
Exhibit 21: Opportunity analysis for global female contraceptive market by product segmentation
Exhibit 22: Global female contraceptive device market 2015-2020 ($ billions)
Exhibit 23: Global female contraceptive device market by type 2015-2020
Exhibit 24: Global IUD market 2015-2020 ($ millions)
Exhibit 25: Global sterilization market 2015-2020 ($ millions)
Exhibit 26: Global subdermal contraceptive implant market 2015-2020 ($ millions)
Exhibit 27: Global vaginal ring market 2015-2020 ($ millions)
Exhibit 28: Global female condom market 2015-2020 ($ millions)
Exhibit 29: Global non-surgical permanent contraception market 2015-2020 ($ millions)
Exhibit 30: Global contraceptive diaphragm market 2015-2020 ($ millions)
Exhibit 31: Global contraceptive sponge market 2015-2020 ($ millions)
Exhibit 32: Global female contraceptive drug market 2015-2020 ($ billions)
Exhibit 33: Global female contraceptive market by type 2015 and 2020
Exhibit 34: Global birth control pill market 2015-2020 ($ millions)
Exhibit 35: Global emergency pill market 2015-2020 ($ millions)
Exhibit 36: Key leading countries in emergency pills
Exhibit 37: Unplanned pregnancies by region (millions)
Exhibit 38: Impact of drivers
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Non-contraceptive health benefits
Exhibit 41: Population of women using birth pills for non-contraceptive reasons
Exhibit 42: Competitive parameters in global female contraceptive market
Exhibit 43: Strategic success factor of companies
Exhibit 44: Key takeaways
Exhibit 45: Key takeaways
Exhibit 46: Pfizer: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Afaxys
  • Ansell
  • Female Health
  • HLL Lifecare
  • Lupin Pharmaceuticals
  • Okamoto Industries
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

New Report Released: – Global Female Contraceptive Market 2016-2020

The author of the report recognizes the following companies as the key players in the global female contraceptive market: Allergan, Merck Millipore, Pfizer, and Teva

Other Prominent Vendors in the market are: Afaxys, Agile Therapeutics, Ansell, Bayer Pharma, Caya, Ferring Pharmaceuticals, Female Health, Fuji Latex, HLL Lifecare, Janssen Pharmaceuticals, Lipocine, Lupin Pharmaceuticals, Mayer Laboratories, Okamoto Industries, Reckitt Benckiser, Syzygy Healthcare, and V-Care Pharma

Commenting on the report, an analyst from the research team said: “Female contraceptives such as birth control pills are generally consumed to prevent pregnancy. However, their consumption has increased over time for other purposes other than avoiding pregnancy. In 2013, 1.5 million women globally used oral contraceptive pills for non-contraceptive benefits, like relief from menstrual pain, polycystic ovarian disease, reduction of acne, and regulation of the menstrual cycle.”

According to the report, innovation and effectiveness of female contraceptives constitute the key to market growth. Several vendors are entering into strategic alliances and investing in R&D for product innovation and better financial stability, thereby developing the latest products with better efficiency, safety, and protection. These strategic decisions help companies generate revenue and acquire a significant share of the market.

Further, the report states that sexual norms, behaviors, and attitudes are undergoing a transformation globally. There has been an increase in the exploration of sexual fantasies because of increased exposure to the internet, TV shows, and erotic fiction like the Fifty Shades of Grey. The current generation is embracing changes in the perception toward experimentation regarding sex. They are also aware of the importance of protection during sex. IUDs and contraceptive pills help in preventing pregnancy for a longer duration of time if taken in the right way. Despite the economic slowdown, there are new as well as niche players entering the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

- Allergan
- Merck Millipore
- Pfizer
- Teva
- Afaxys
- Agile Therapeutics
- Ansell
- Bayer Pharma
- Caya
- Ferring Pharmaceuticals
- Female Health
- Fuji Latex
- HLL Lifecare
- Janssen Pharmaceuticals
- Lipocine
- Lupin Pharmaceuticals
- Mayer Laboratories
- Okamoto Industries
- Reckitt Benckiser
- Syzygy Healthcare
- V-Care Pharma
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll